BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 7092406)

  • 1. Biochemical cardiac risk factors during diuretic therapy.
    Hubbell FA; Weber MA; Winer RL; Rose DE
    Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):123-33. PubMed ID: 7092406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of diuretic therapy on serum lipoproteins: an undesirable effect?].
    Glück Z; Weidmann P; Mordasini R; Peheim E; Bachmann C; Keusch G; Riesen W
    Schweiz Med Wochenschr; 1979 Jan; 109(4):104-8. PubMed ID: 219471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do beta-blockers alter lipids and what are the consequences?
    Holtzman E; Rosenthal T; Goldbourt U; Segal P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cholesterol during treatment of hypertension with diuretic drugs.
    Ames RP; Peacock PB
    Arch Intern Med; 1984 Apr; 144(4):710-4. PubMed ID: 6712367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status.
    Holtzman E; Rosenthal T; Goldbourt U; Segal P
    Isr J Med Sci; 1984 Dec; 20(12):1169-76. PubMed ID: 6519949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mefruside treatment in hypertension.
    Henningsen NC; Bergengren B; Malmborg O; Pihl O; Renmarker K; Strand L
    Acta Med Scand; 1980; 208(4):272-8. PubMed ID: 7446207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P; de Courten M; Ferrari P; Böhlen L
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
    Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prazosin on blood lipids and on thyroid function in hypertensive patients.
    Velasco M; Silva H; Morillo J; Pellicer R; Urbina-Quintana A; Hernández-Pieretti O
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S225-7. PubMed ID: 6177961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uricosuric action of a new beta receptor blocker-diuretic drug combination].
    Brandstetter G; Hoffmann H; Maderbacher H; Eslaminejad S
    Acta Med Austriaca; 1986; 13(2):29-37. PubMed ID: 2876573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive therapy and the risk of coronary heart disease.
    Ames RP; Hill P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S206-12. PubMed ID: 6177958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretic treatment and serum lipoproteins: effects of tienilic acid and indapamide.
    Weidmann P; Meier A; Mordasini R; Riesen W; Bachmann C; Peheim E
    Klin Wochenschr; 1981 Apr; 59(7):343-6. PubMed ID: 7241956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Betaxolol in obese hypertensive patients. Long-term effects on blood pressure and serum lipids.
    van Os JS; van Brummelen P; Woittiez AJ
    Neth J Med; 1992 Jun; 40(5-6):227-31. PubMed ID: 1436258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies in asymptomatic primary hyperlipidaemia. IV. ECG at rest and during exercise and its relation to various lipoprotein classes.
    Olsson AG; Ekelund LG; Carlson LA
    Acta Med Scand; 1975; 198(1-2):55-73. PubMed ID: 170796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On metabolic effects of diuretics and beta-blockers. Results from a cross-sectional and longitudinal population study of women.
    Bengtsson C; Lennartsson J; Lindquist O; Lindstedt G; Lundberg PA; Noppa H; Sigurdsson JA; Tibblin E
    Acta Med Scand; 1982; 212(1-2):57-64. PubMed ID: 6127000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of tienilic acid, a new diuretic uricosuric agent, in the therapy of arterial hypertension.
    Lechi A; Covi G; Danti G; Riva AD; Pedrolli E; Pomari S
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():367s-269s. PubMed ID: 396083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
    Nash AL; Cornish EJ; Hain R
    Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.